Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

HyperRAB SD

Biological Immunology

NDC 13533-618-10

Open in the dashboard

General payments

$147,719

372 payments

Research payments

$0

0 payments

Through program year 2020, $147,719 in general payments and $0 in research payments were reported against HyperRAB SD (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $18,413 40
2019 General $129,306 332

Breakdown

Who paid General payments · program years 2019–2020
  1. Grifols USA, LLC $147,629 370 payments
  2. Grifols Shared Services North America, Inc. $90 2 payments
Top recipients General payments · program year 2020
  1. Stephen Scholand Infectious Disease · Meriden, CT $10,903 59% · 13 payments
  2. Fredrick Melik-Abrahamian Emergency Medicine · Sylmar, CA $6,838 37% · 4 payments
  3. Kumar Alagappan Emergency Medicine · Houston, TX $360 2% · 1 payment
  4. Olly Duckett Emergency Medicine · Raleigh, NC $18 <1% · 1 payment
  5. Charles Eaves Emergency Medicine · Marianna, FL $18 <1% · 1 payment

The top 5 of 25 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Infectious Disease Internal Medicine $10,903 59% · 1 practitioner
  2. Emergency Medicine $7,413 40% · 17 practitioners
  3. Internal Medicine $28 <1% · 2 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $16 <1% · 1 practitioner
  5. Family Medicine $16 <1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Connecticut $10,903 59% · 1 recipient
  2. California $6,838 37% · 1 recipient
  3. Texas $360 2% · 1 recipient
  4. New Jersey $66 <1% · 5 recipients
  5. Alabama $64 <1% · 5 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

372 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record